Jiangsu Coben Pharmaceutical Co., Ltd

Founded in 2005, Coben Group was designed and built according to GMP standard with a total area of 100,000㎡. We are a member of WZ Group, a Global Fortune 500 company ranked No.138 in 2023. Coben is specialized in developing and manufacturing of APIs and intermediates. Main products include: Tranexamic Acid, Oseltamivir , Xanomeline , α-Lipoic Acid , Mebeverine hydrochloride and their intermediates. Coben is also an internationally recognized pharmaceutical contract development and manufacturing organization (CDMO).